Nationwide Fund Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-168,431
| Closed | -$2.1M | – | 3255 |
|
|
2016
Q4 | $2.1M | Sell |
168,431
-7,097
| -4% | -$85.5K | 0.01% | 1391 |
|
|
2016
Q3 | $2.4M | Buy |
175,528
+18,730
| +12% | +$188K | 0.01% | 1304 |
|
|
2016
Q2 | $1.16M | Buy |
156,798
+49,171
| +46% | +$369K | 0.01% | 1638 |
|
|
2016
Q1 | $706K | Sell |
107,627
-3,209
| -3% | -$18K | ﹤0.01% | 1895 |
|
|
2015
Q4 | $693K | Buy |
110,836
+2,230
| +2% | +$14.6K | ﹤0.01% | 1922 |
|
|
2015
Q3 | $634K | Hold |
108,606
| – | – | ﹤0.01% | 1965 |
|
|
2015
Q2 | $898K | Sell |
108,606
-12,143
| -10% | -$107K | ﹤0.01% | 1923 |
|
|
2015
Q1 | $995K | Sell |
120,749
-4,530
| -4% | -$33.5K | ﹤0.01% | 1882 |
|
|
2014
Q4 | $861K | Sell |
125,279
-2,056
| -2% | -$12.9K | ﹤0.01% | 1887 |
|
|
2014
Q3 | $688K | Buy |
127,335
+289
| +0.2% | +$1.69K | ﹤0.01% | 2029 |
|
|
2014
Q2 | $809K | Buy |
+127,046
| New | +$874K | ﹤0.01% | 1996 |
|
|
2014
Q1 | – | Sell |
-8,700
| Closed | -$59K | – | 3268 |
|
|
2013
Q4 | $59K | Sell |
8,700
-121,500
| -93% | -$656K | ﹤0.01% | 3051 |
|
|
2013
Q3 | $2.4M | Buy |
130,200
+4,500
| +4% | +$87.4K | 0.01% | 1309 |
|
|
2013
Q2 | $2.2M | Buy |
+125,700
| New | +$2.23M | 0.01% | 1237 |
|
Other funds holding ARIA
Nationwide Fund Advisors's ARIA Position: Q1 2017 in Review
Nationwide Fund Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 168,431 shares — an estimated $2.1M sold.
Nationwide Fund Advisors first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $2.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Nationwide Fund Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 168,431 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.1M.
- Nationwide Fund Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Nationwide Fund Advisors's Ariad Pharmaceuticals Inc position peaked at $2.4M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Nationwide Fund Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.